Milprazikan Dog – Vermifuge – 12,5 MG / 125 MG – CLÉMENT THÉKAN

Do not use in dogs weighing less than 5 kg.

Do not use in case of hypersensitivity to the active substances or to any of the excipients.

In animals:
Studies performed with milbemycin oxime indicate that the margin of safety in some Collie dogs or related canine breeds is lower than in other breeds. In these dogs, the recommended dosage should be strictly adhered to.
The tolerance of the product in young puppies of these breeds has not been studied.
The clinical signs in Collies are similar to those observed in dogs of other breeds subjected to an overdose (see also the section "Overdose" in the legal notices).
In accordance with good veterinary practice, animals should be weighed to ensure accurate dosing.
Treatment of dogs with large numbers of circulating microfilariae may occasionally result in the development of hypersensitivity reactions such as pale mucous membranes, vomiting, tremors, labored breathing or excessive salivation. These reactions are associated with the release of proteins from dead or dying microfilariae and are not a direct toxic effect of the product. The use of the product in dogs suffering from microfilaraemia is therefore not recommended.
In areas affected by heartworm disease or when it is known that a dog has been or is going to go to a risk area, a veterinary examination is recommended before using the product, to exclude the presence of any infestation. concomitant by Unforgiving heartworms. In the event of a positive diagnosis, adulticidal therapy is indicated before administration of the product.
Echinococcosis poses a danger to human beings. In the event of echinococcosis, specific protocols for the treatment, follow-up and protection of persons must be followed. It is then advisable to consult an expert or a parasitology center. If the dog has gone to an area where Echinococcus species is widespread, consult a veterinarian.
No studies have been conducted in dogs that are severely debilitated or have significant renal or hepatic impairment. The product is not recommended in these cases or only after evaluation of the risk/benefit ratio by the veterinarian.
In dogs less than 4 weeks old, tapeworm infestations are rare. Treatment of animals under 4 weeks of age with a combination product may not be necessary.In the person administering the veterinary medicinal product to animals:
Wash hands after use. In case of accidental ingestion of tablets, especially by children, seek medical advice immediately and show the carton or package leaflet to the doctor.